Results 41 to 50 of about 16,917 (221)

DYSGEUSIA-A REVIEW [PDF]

, 2013
Dysgeusia, is distortion of the sense of taste.  It is an abnormality in patient ability to detect the four standard taste stimuli (salt, sweat, sour, bitter) or electric stimuli (electrogustometry).
M.SUBHA, VELMURUGAN
core   +1 more source

Dosiomic-based prediction of dysgeusia in head & neck cancer patients treated with radiotherapy

, 2023
Purpose: To investigate the potential of dosiomics in predicting radiotherapy-induced taste distortion (dysgeusia) in head & neck (H&N) cancer. Methods: A cohort of 80 H&N cancer patients treated with radical or adjuvant radiotherapy and with a follow-up
Fiorentin D., Dusi F., Anile G., Ferrari M., Paiusco M., Scaggion A., Busato F., Bettinelli A., Nicolai P., Marturano F., Ghi M. G.   +10 more
core   +1 more source

Taste impairment after endoscopic stapes surgery: Do anatomic variability of chorda tympani and surgical technique matter? : Post-operative dysgeusia after EStS. [PDF]

, 2022
PURPOSE To investigate how the anatomical configuration of the oval window region (OWR) influences the management of the chorda tympani (ChT) and the curetting of adjacent bony structures, in a setting of patients undergoing endoscopic stapes surgery (
Bonali, Marco, Anschuetz, Lukas, Alicandri-Ciufelli, Matteo, Reale, Marella, Molinari, Giulia, Presutti, Livio, Lucidi, Daniela   +6 more
core   +1 more source

Exploring the impact of dysgeusia on sensory perception, appetite, and texture during oral nutritional supplement consumption in head and neck cancer and multiple myeloma patients

Clinical Nutrition Open Science
SUMMARY: Dysgeusia, an altered taste perception commonly experienced by cancer patients undergoing chemotherapy or radiotherapy, significantly impacts their sensory perception, appetite, and compliance with oral nutritional supplements (ONS), essential ...
Ghias Kulsoom, Krawczyk Janusz, Gupta Ananya   +2 more
doaj   +1 more source

P47 | UTILITY AND SENSITIVITY OF WETT-SA53 TO MEASURE DYSGEUSIA ASSOCIATED WITH TALQUETAMAB, A GPRC5D×CD3 BISPECIFIC ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: PRELIMINARY DATA FROM THE TALISMAN STUDY

Haematologica
Introduction. Talquetamab (Tal) is a GPRC5D×CD3 bispecific antibody approved for the treatment of relapsed/refractory multiple myeloma (RRMM). Early oral adverse event (AEs) onset, including dysgeusia, can impact patient (pt) quality of life.
R. Popat, N.W.C.J. Van De Donk, B. Faiman, J. Yuda, K. Kim, A. Costa, A. Laheij, R.L. Doty, J. Omel, B. Lipe, L. Sanchez, A. Chari, A. Lin, H. Sroussi, M. Fernandez, K.S. Gray, G. Aguilar, K. Bolyard, J. Schultz, K. Qi, D. Cortes-Selva, J. Zhang, C. Heuck, K. Hawks, K. Tian, M. França, L. Rasche   +26 more
doaj   +1 more source

Managing Severe Dysgeusia and Dysosmia in Lung Cancer Patients: A Systematic Scoping Review

Frontiers in Oncology, 2021
IntroductionLung cancer (LC) is highly prevalent worldwide, with elevated mortality. In this population, taste and smell alterations (TSAs) are frequent but overlooked symptoms.
Ana Sofia Spencer, David da Silva Dias, David da Silva Dias, David da Silva Dias, Manuel Luís Capelas, Manuel Luís Capelas, Francisco Pimentel, Teresa Santos, Teresa Santos, Teresa Santos, Teresa Santos, Pedro Miguel Neves, Pedro Miguel Neves, Antti Mäkitie, Antti Mäkitie, Antti Mäkitie, Paula Ravasco, Paula Ravasco, Paula Ravasco, Paula Ravasco   +19 more
doaj   +1 more source

Reflex seizures and epilepsy surgery: A network approach case‐based exploration

Epileptic Disorders, EarlyView.
Abstract Context Reflex seizures (RS) are defined by their consistent provocation by specific stimuli, encompassing a broad range from elementary sensory inputs to complex cognitive tasks. While RS are often encountered in clinical practice, their surgical management remains sparsely reported and poorly systematized.
Olivier Aron, Laure Salmon, Nicolas Nguyen, Dènahin Toffa, Sami Obaid, Alexis Robin, Dang Khoa Nguyen   +6 more
wiley   +1 more source

Carbonation dysgeusia associated with topiramate

American Journal of Health-System Pharmacy, 2020
AbstractPurposeA case of carbonation dysgeusia associated with the use of topiramate is reported in order to bring awareness to a lesser-known adverse effect of the medication so that providers may be able to more effectively counsel patients and provide potential solutions.SummaryA 39-year-old Caucasian woman with longstanding epilepsy was initiated ...
Maria, Charbonneau, Courtney, Doyle-Campbell, Corey, Laskey, Kam, Capoccia   +3 more
openaire   +2 more sources

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development

Epilepsia, EarlyView.
Abstract This article summarizes data for 13 investigational treatments for which at least preliminary seizure outcome data in patients with epilepsy were reported at the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices held in Madrid, Spain, on May 3–6, 2026.
Meir Bialer, Cecilie Johannessen Landmark, Matthias J. Koepp, Emilio Perucca, Piero Perucca, Torbjörn Tomson, H. Steve White, Elaine Wirrell   +7 more
wiley   +1 more source

Twelve‐Month Outcomes of a Preventive Dysphagia Intervention in Patients With Head and Neck Cancer—A Randomized Study

Head &Neck, EarlyView.
ABSTRACT Background Radiation‐associated dysphagia is common after radiotherapy for head and neck cancer and may occur early or years later. The effect of preventive exercises might be undermined by poor adherence. Aim To evaluate the effect of a simple preventive exercise protocol on swallowing function up to 12 months after radiotherapy.
Kerstin Petersson, Signe Rödseth Smith, Charlotte Johansson‐Malmeling, Caterina Finizia, Lisa Tuomi   +4 more
wiley   +1 more source